The samples were screened for large deletions/duplications by multiplex ligation-dependent probe amplification (MLPA). MLPA is a method for copy number detection by the multiplex PCR method. Small (50–70 nt) sequences are targeted, enabling MLPA to identify single exon aberrations. The samples were ligated and amplified using the SALSA MLPA P003
MLH1/
MSH2 probe mix version B2 according to the protocol manufacturer's recommendation (MRC-Holland). The P003
MLH1/
MSH2 probe mix version 2 contains probes for each of the 19 exons of the
MLH1 gene and for each of the 16 exons of the
MSH2 gene. Also, 2 probes are included for the most 3′ exon of
EPCAM, a gene located just upstream of the
MSH2 gene. Deletions of the most 3′ exon of the
EPCAM gene can result in silencing of the
MSH2 gene. In addition, the P003
MLH1/
MSH2 probe mix also covers 7 genes in the
CDKN2A-9p21 region +
PAX5 (9p13)
DOCK8 (9p24.3), and
GLDC (9p21.1). The samples were analyzed on a
CEQTM 8000 GeneticAnalysis System (Beckman Coulter Inc.). Data normalization and analysis were performed with GeneMarker Software version 1.75 (SoftGenetics) using standard parameters.
Andersson U., Wibom C., Cederquist K., Aradottir S., Borg Å., Armstrong G.N., Shete S., Lau C.C., Bainbridge M.N., Claus E.B., Barnholtz-Sloan J., Lai R., Il'yasova D., Houlston R.S., Schildkraut J., Bernstein J.L., Olson S.H., Jenkins R.B., Lachance D.H., Wrensch M., Davis F.G., Merrell R., Johansen C., Sadetzki S., Bondy M.L., Melin B.S., Adatto P., Morice F., Payen S., McQuinn L., McGaha R., Guerra S., Paith L., Roth K., Zeng D., Zhang H., Yung A., Aldape K., Gilbert M., Weinberger J., Colman H., Conrad C., de Groot J., Forman A., Groves M., Levin V., Loghin M., Puduvalli V., Sawaya R., Heimberger A., Lang F., Levine N., Tolentino L., Saunders K., Thach T.T., Iacono D.D., Sloan A., Gerson S., Selman W., Bambakidis N., Hart D., Miller J., Hoffer A., Cohen M., Rogers L., Nock C.J., Wolinsky Y., Devine K., Fulop J., Barrett W., Shimmel K., Ostrom Q., Barnett G., Rosenfeld S., Vogelbaum M., Weil R., Ahluwalia M., Peereboom D., Staugaitis S., Schilero C., Brewer C., Smolenski K., McGraw M., Naska T., Rosenfeld S., Ram Z., Blumenthal D.T., Bokstein F., Umansky F., Zaaroor M., Cohen A., Tzuk-Shina T., Voldby B., Laursen R., Andersen C., Brennum J., Henriksen M.B., Marzouk M., Davis M.E., Boland E., Smith M., Eze O., Way M., Lada P., Miedzianowski N., Frechette M., Paleologos N., Byström G., Svedberg E., Huggert S., Kimdal M., Sandström M., Brännström N., Hayat A., Tihan T., Zheng S., Berger M., Butowski N., Chang S., Clarke J., Prados M., Rice T., Sison J., Kivett V., Duo X., Hansen H., Hsuang G., Lamela R., Ramos C., Patoka J., Wagenman K., Zhou M., Klein A., McGee N., Pfefferle J., Wilson C., Morris P., Hughes M., Britt-Williams M., Foft J., Madsen J., Polony C., McCarthy B., Zahora C., Villano J., Engelhard H., Borg A., Chanock S.K., Collins P., Elston R., Kleihues P., Kruchko C., Petersen G., Plon S., Thompson P., Johansen C., Sadetzki S., Melin B., Bondy M.L., Lau C.C., Scheurer M.E., Armstrong G.N., Liu Y., Shete S., Yu R.K., Aldape K.D., Gilbert M.R., Weinberg J., Houlston R.S., Hosking F.J., Robertson L., Papaemmanuil E., Claus E.B., Claus E.B., Barnholtz-Sloan J., Sloan A.E., Barnett G., Devine K., Wolinsky Y., Lai R., McKean-Cowdin R., Il'yasova D., Schildkraut J., Sadetzki S., Yechezkel G.H., Bruchim R.B., Aslanov L., Sadetzki S., Johansen C., Kosteljanetz M., Broholm H., Bernstein J.L., Olson S.H., Schubert E., DeAngelis L., Jenkins R.B., Yang P., Rynearson A., Andersson U., Wibom C., Henriksson R., Melin B.S., Cederquist K., Aradottir S., Borg Å., Merrell R., Lada P., Wrensch M., Wiencke J., Wiemels J., McCoy L., McCarthy B.J, & Davis F.G. (2014). Germline rearrangements in families with strong family history of glioma and malignant melanoma, colon, and breast cancer. Neuro-Oncology, 16(10), 1333-1340.